Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...

Yesterday the US Food and Drug Administration (FDA) approved a freeze-dried formulation of Bavarian Nordic's mpox vaccine, ...

This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...

Bavarian Nordic has won US Food and Drug Administration (FDA) approval for its chikungunya vaccine Vimkunya, becoming the ...

Several Democratic-led states have taken legal action against the Trump administration over its decision to retract $11 ...

After a four-year buildout, Bavarian Nordic's travel health business is starting to bear fruit ahead of the company's chikungunya vaccine launch.

The latest health updates include the FDA's approval of a new freeze-dried mpox vaccine, and a judge's dismissal of a $10 ...

Good day and thank you for standing by. Welcome to the Bavarian Nordic 2024 Annual Report Conference call. At this time all participants are in a listen-only mode. After the speakers' presentation ...

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US Government to add to vaccine ...

The Company has been contracted by the U.S Biomedical Advanced Research and Development Authority (BARDA) to develop and supply a freeze-dried version of JYNNEOS for stockpiling. Manufacturing under ...